CRISPR crops—exempt from GMO regulations—reaching US market in record time

CRISPR–Cas9-edited plants can be cultivated and sold free from regulation, the US Department of Agriculture (USDA) is making increasingly clear. The agency gave a free pass to Camelina sativa, or false flax, with enhanced omega-3 oil. And more recently, in October, said that a drought-tolerant soybean variety developed with CRISPR falls outside of its regulatory purview. This laissez-faire attitude from the agency shaves years and tens of millions of dollars off the cost of bringing a biotech plant to market.

It would have taken Yield10 at least six years and $30–50 million to test and collect the data necessary to bring genetically engineered camelina through the full USDA regulatory process, says Peoples. “We did this in two years and [USDA’s decision] took two months, and I assure you we didn’t spend $30 million on it,” he says. The company will present its technology to the US Food and Drug Administration’s voluntary review process, he says.

The edited camelina and the drought-tolerant soybean developed by scientists at USDA’s research arm are two of at least five CRISPR–Cas9-edited organisms to sidestep USDA’s regulatory system in the last two years.

Screen Shot at AM

Read full, original post: With a free pass, CRISPR-edited plants reach market in record time

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.